Global Influenza Treatment Market 2020-2030 by Product Type, Influenza Type, Administration Route, Distribution Channel, and Region: Trend Forecast and Growth Opportunity

About the Report

About the Report

Global influenza treatment market will reach USD 1,371.0 billion by 2030, growing by 3.8% annually over 2020-2030 driven by rising incidences of influenza, growing awareness and need for new drugs and treatment across the globe.

Highlighted with 83 tables and 77 figures, this 156-page report Global Influenza Treatment Market 2020-2030 by Product Type, Influenza Type, Administration Route, Distribution Channel, and Region: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire global influenza treatment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

Market Structure

Growth Drivers

Restraints and Challenges

Emerging Product Trends & Market Opportunities

Porter's Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global influenza treatment market in every aspect of the classification from perspectives of Product Type, Influenza Type, Administration Route, Distribution Channel, and Region.

Based on Product Type, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Oseltamivir Phosphate

Baloxavir Marboxil

Peramivir

Zanamivir

Other Drugs

Based on Influenza Type, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Influenza A

Influenza B

Influenza C

Based on Administration Route, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Oral Administration

Other Administration Routes

Based on Distribution Channel, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Retail Pharmacy

Hospital Pharmacy

Clinics

Online Stores

Geographically, the following regions together with the listed national/local markets are fully investigated:

APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)

Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)

North America (U.S., Canada, and Mexico)

South America (Brazil, Chile, Argentina, Rest of South America)

RoW (Saudi Arabia, UAE, South Africa)

For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Product Type, Administration Route, and Distribution Channel over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in global influenza treatment market are assayed quantitatively and qualitatively through GMD's Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):

AstraZeneca Plc

BioCryst Pharmaceuticals Inc.

Biondvax

Daiichi Sankyo Company

F. Hoffmann-La Roche Ltd. (Genentech USA, Inc.)

GlaxoSmithKline Plc

Mylan N.V

Natco Pharma Limited

Novartis AG

Sanofi

Seqirus

Teva Pharmaceutical Industries Limited

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Products


Companies

Key Players (this may not be a complete list and extra companies can be added upon request):

AstraZeneca Plc

BioCryst Pharmaceuticals Inc.

Biondvax

Daiichi Sankyo Company

F. Hoffmann-La Roche Ltd. (Genentech USA, Inc.)

GlaxoSmithKline Plc

Mylan N.V

Natco Pharma Limited

Novartis AG

Sanofi

Seqirus

Teva Pharmaceutical Industries Limited

Table of Contents

Table of Contents

1 Introduction 8

1.1 Industry Definition and Research Scope 8

1.1.1 Industry Definition 8

1.1.2 Research Scope 9

1.2 Research Methodology 12

1.2.1 Overview of Market Research Methodology 12

1.2.2 Market Assumption 13

1.2.3 Secondary Data 13

1.2.4 Primary Data 13

1.2.5 Data Filtration and Model Design 15

1.2.6 Market Size/Share Estimation 16

1.2.7 Research Limitations 17

1.3 Executive Summary 18

2 Market Overview and Dynamics 20

2.1 Market Size and Forecast 20

2.1.1 Impact of COVID-19 on the Market 21

2.2 Major Growth Drivers 23

2.3 Market Restraints and Challenges 27

2.4 Emerging Opportunities and Market Trends 30

2.5 Porter's Fiver Forces Analysis 34

3 Segmentation of Global Market by Product Type 38

3.1 Market Overview by Product Type 38

3.2 Oseltamivir Phosphate 40

3.3 Baloxavir Marboxil 41

3.4 Peramivir 42

3.5 Zanamivir 43

3.6 Other Drugs 44

4 Segmentation of Global Market by Influenza Type 45

4.1 Market Overview by Influenza Type 45

4.2 Influenza A 47

4.3 Influenza B 48

4.4 Influenza C 49

5 Segmentation of Global Market by Administration Route 50

5.1 Market Overview by Administration Route 50

5.2 Oral Administration 52

5.3 Other Administration Routes 53

6 Segmentation of Global Market by Distribution Channel 54

6.1 Market Overview by Distribution Channel 54

6.2 Retail Pharmacy 56

6.3 Hospital Pharmacy 57

6.4 Clinics 58

6.5 Online Stores 59

7 Segmentation of Global Market by Region 60

7.1 Geographic Market Overview 2019-2030 60

7.2 North America Market 2019-2030 by Country 66

7.2.1 Overview of North America Market 66

7.2.2 U.S. 70

7.2.3 Canada 74

7.2.4 Mexico 76

7.3 European Market 2019-2030 by Country 78

7.3.1 Overview of European Market 78

7.3.2 Germany 82

7.3.3 UK 84

7.3.4 France 86

7.3.5 Spain 88

7.3.6 Italy 90

7.3.7 Russia 92

7.3.8 Rest of European Market 94

7.4 Asia-Pacific Market 2019-2030 by Country 96

7.4.1 Overview of Asia-Pacific Market 96

7.4.2 Japan 100

7.4.3 China 103

7.4.4 Australia 105

7.4.5 India 107

7.4.6 South Korea 109

7.4.7 Rest of APAC Region 111

7.5 South America Market 2019-2030 by Country 113

7.5.1 Argentina 116

7.5.2 Brazil 118

7.5.3 Chile 120

7.5.4 Rest of South America Market 122

7.6 MEA Market 2019-2030 by Country 123

7.6.1 UAE 126

7.6.2 Saudi Arabia 128

7.6.3 South Africa 130

7.6.4 Other National Markets 132

8 Competitive Landscape 133

8.1 Overview of Key Vendors 133

8.2 New Product Launch, Partnership, Investment, and M&A 136

8.3 Company Profiles 137

AstraZeneca Plc 137

BioCryst Pharmaceuticals Inc. 139

Biondvax 140

Daiichi Sankyo Company 141

F. Hoffmann-La Roche Ltd. (Genentech USA, Inc.) 142

GlaxoSmithKline Plc 143

Mylan N.V 144

Natco Pharma Limited 145

Novartis AG 146

Sanofi 147

Seqirus 148

Teva Pharmaceutical Industries Limited 149

9 Investing in Global Market: Risk Assessment and Management 150

9.1 Risk Evaluation of Global Market 150

9.2 Critical Success Factors (CSFs) 153

Related Reports and Products 156


List of Figure

Figure 1. Research Method Flow Chart 12

Figure 2. Breakdown of Primary Research 14

Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 16

Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 18

Figure 5. Global Influenza Treatment Market, 2019-2030, USD mn 20

Figure 6. Impact of COVID-19 on Business 21

Figure 7. Primary Drivers and Impact Factors of Global Influenza Treatment Market 23

Figure 8. GDP per capita in the World, 1960-2018, USD thousand 26

Figure 9. Forecast of Middle-class Population by Region, 2015-2030, million 26

Figure 10. Primary Restraints and Impact Factors of Global Influenza Treatment Market 27

Figure 11. Investment Opportunity Analysis 31

Figure 12. Porter's Fiver Forces Analysis of Global Influenza Treatment Market 34

Figure 13. Breakdown of Global Influenza Treatment Market by Product Type, 2019-2030, % of Revenue 38

Figure 14. Global Addressable Market Cap in 2020-2030 by Product Type, Value (USD mn) and Share (%) 39

Figure 15. Global Influenza Treatment Market: Oseltamivir Phosphate, 2019-2030, USD mn 40

Figure 16. Global Influenza Treatment Market: Baloxavir Marboxil, 2019-2030, USD mn 41

Figure 17. Global Influenza Treatment Market: Peramivir, 2019-2030, USD mn 42

Figure 18. Global Influenza Treatment Market: Zanamivir, 2019-2030, USD mn 43

Figure 19. Global Influenza Treatment Market: Other Drugs, 2019-2030, USD mn 44

Figure 20. Breakdown of Global Influenza Treatment Market by Influenza Type, 2019-2030, % of Sales Revenue 45

Figure 21. Global Addressable Market Cap in 2020-2030 by Influenza Type, Value (USD mn) and Share (%) 46

Figure 22. Global Influenza Treatment Market: Influenza A, 2019-2030, USD mn 47

Figure 23. Global Influenza Treatment Market: Influenza B, 2019-2030, USD mn 48

Figure 24. Global Influenza Treatment Market: Influenza C, 2019-2030, USD mn 49

Figure 25. Breakdown of Global Influenza Treatment Market by Administration Route, 2019-2030, % of Sales Revenue 50

Figure 26. Global Addressable Market Cap in 2020-2030 by Administration Route, Value (USD mn) and Share (%) 51

Figure 27. Global Influenza Treatment Market: Oral Administration, 2019-2030, USD mn 52

Figure 28. Global Influenza Treatment Market: Other Administration Routes, 2019-2030, USD mn 53

Figure 29. Breakdown of Global Influenza Treatment Market by Distribution Channel, 2019-2030, % of Revenue 54

Figure 30. Global Addressable Market Cap in 2020-2030 by Distribution Channel, Value (USD mn) and Share (%) 55

Figure 31. Global Influenza Treatment Market: Retail Pharmacy, 2019-2030, USD mn 56

Figure 32. Global Influenza Treatment Market: Hospital Pharmacy, 2019-2030, USD mn 57

Figure 33. Global Influenza Treatment Market: Clinics, 2019-2030, USD mn 58

Figure 34. Global Influenza Treatment Market: Online Stores, 2019-2030, USD mn 59

Figure 35. Global Market Snapshot by Region 60

Figure 36. Geographic Spread of Worldwide Influenza Treatment Market, 2019-2030, % of Sales Revenue 61

Figure 37. Global Addressable Market Cap in 2020-2030 by Region, Value (USD mn) and Share (%) 62

Figure 38. Health Spending as a Share of GDP by Country, 2015 and 2030 64

Figure 39. North American Influenza Treatment Market, 2019-2030, USD mn 67

Figure 40. Breakdown of North America Influenza Treatment Market by Country, 2019 and 2030, % of Revenue 68

Figure 41. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value (USD mn) and Share (%) 69

Figure 42. U.S. Influenza Treatment Market, 2019-2030, USD mn 71

Figure 43. Canada Influenza Treatment Market, 2019-2030, USD mn 74

Figure 44. Influenza Treatment Market in Mexico, 2015-2030, USD mn 76

Figure 45. European Influenza Treatment Market, 2019-2030, USD mn 79

Figure 46. Breakdown of European Influenza Treatment Market by Country, 2019 and 2030, % of Revenue 80

Figure 47. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value (USD mn) and Share (%) 81

Figure 48. Influenza Treatment Market in Germany, 2019-2030, USD mn 82

Figure 49. Influenza Treatment Market in UK, 2019-2030, USD mn 84

Figure 50. Influenza Treatment Market in France, 2019-2030, USD mn 86

Figure 51. Influenza Treatment Market in Spain, 2019-2030, USD mn 88

Figure 52. Influenza Treatment Market in Italy, 2019-2030, USD mn 90

Figure 53. Influenza Treatment Market in Russia, 2019-2030, USD mn 92

Figure 54. Influenza Treatment Market in Rest of Europe, 2019-2030, USD mn 94

Figure 55. Asia-Pacific Influenza Treatment Market, 2019-2030, USD mn 97

Figure 56. Breakdown of APAC Influenza Treatment Market by Country, 2019 and 2030, % of Revenue 97

Figure 57. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value (USD mn) and Share (%) 99

Figure 58. Influenza Treatment Market in Japan, 2019-2030, USD mn 101

Figure 59. Influenza Treatment Market in China, 2019-2030, USD mn 103

Figure 60. Influenza Treatment Market in Australia, 2019-2030, USD mn 105

Figure 61. Influenza Treatment Market in India, 2019-2030, USD mn 107

Figure 62. Influenza Treatment Market in South Korea, 2019-2030, USD mn 109

Figure 63. Influenza Treatment Market in Rest of APAC, 2019-2030, USD mn 111

Figure 64. South America Influenza Treatment Market, 2019-2030, USD mn 114

Figure 65. Breakdown of South America Influenza Treatment Market by Country, 2019 and 2030, % of Revenue 114

Figure 66. Contribution to South America 2020-2030 Cumulative Revenue by Country, Value (USD mn) and Share (%) 115

Figure 67. Influenza Treatment Market in Argentina, 2019-2030, USD mn 116

Figure 68. Influenza Treatment Market in Brazil, 2019-2030, USD mn 118

Figure 69. Influenza Treatment Market in Chile, 2019-2030, USD mn 120

Figure 70. Influenza Treatment Market in Rest of South America, 2019-2030, USD mn 122

Figure 71. Influenza Treatment Market in Middle East and Africa (MEA), 2019-2030, USD mn 124

Figure 72. Breakdown of MEA Influenza Treatment Market by Country, 2019 and 2030, % of Revenue 124

Figure 73. Contribution to MEA 2020-2030 Cumulative Revenue by Country, Value (USD mn) and Share (%) 125

Figure 74. Influenza Treatment Market in UAE, 2019-2030, USD mn 126

Figure 75. Influenza Treatment Market in Saudi Arabia, 2019-2030, USD mn 128

Figure 76. Influenza Treatment Market in South Africa, 2019-2030, USD mn 130

Figure 77. Growth Stage of Global Influenza Treatment Industry over the Forecast Period 133


List of Table

Table 1. Snapshot of Global Influenza Treatment Market, 2019-2030 19

Table 2. Main Product Trends and Market Opportunities in Global Influenza Treatment Market 30

Table 3. Global Influenza Treatment Market by Product Type, 2019-2030, USD mn 38

Table 4. Global Influenza Treatment Market by Influenza Type, 2019-2030, USD mn 45

Table 5. Global Influenza Treatment Market by Administration Route, 2019-2030, USD mn 50

Table 6. Global Influenza Treatment Market by Distribution Channel, 2019-2030, USD mn 54

Table 7. Global Influenza Treatment Market by Region, 2019-2030, USD mn 61

Table 8. Total Health Expenditure per capita in PPP International U.S. Dollars by Country 63

Table 9. Leading National Influenza Treatment Market, 2019 and 2030, USD mn 65

Table 10. North America Influenza Treatment Market by Country, 2019-2030, USD mn 68

Table 11. U.S. Influenza Treatment Market by Product Type, 2019-2030, USD mn 72

Table 12. U.S. Influenza Treatment Market by Administration Route, 2019-2030, USD mn 72

Table 13. U.S. Influenza Treatment Market by Distribution Channel, 2019-2030, USD mn 72

Table 14. Canada Influenza Treatment Market by Product Type, 2019-2030, USD mn 75

Table 15. Canada Influenza Treatment Market by Administration Route, 2019-2030, USD mn 75

Table 16. Canada Influenza Treatment Market by Distribution Channel, 2019-2030, USD mn 75

Table 17. Mexico Influenza Treatment Market by Product Type, 2019-2030, USD mn 77

Table 18. Mexico Influenza Treatment Market by Administration Route, 2019-2030, USD mn 77

Table 19. Mexico Influenza Treatment Market by Distribution Channel, 2019-2030, USD mn 77

Table 20. Europe Influenza Treatment Market by Country, 2019-2030, USD mn 81

Table 21. Germany Influenza Treatment Market by Product Type, 2019-2030, USD mn 83

Table 22. Germany Influenza Treatment Market by Administration Route, 2019-2030, USD mn 83

Table 23. Germany Influenza Treatment Market by Distribution Channel, 2019-2030, USD mn 83

Table 24. UK Influenza Treatment Market by Product Type, 2019-2030, USD mn 85

Table 25. UK Influenza Treatment Market by Administration Route, 2019-2030, USD mn 85

Table 26. UK Influenza Treatment Market by Distribution Channel, 2019-2030, USD mn 85

Table 27. France Influenza Treatment Market by Product Type, 2019-2030, USD mn 87

Table 28. France Influenza Treatment Market by Administration Route, 2019-2030, USD mn 87

Table 29. France Influenza Treatment Market by Distribution Channel, 2019-2030, USD mn 87

Table 30. Spain Influenza Treatment Market by Product Type, 2019-2030, USD mn 89

Table 31. Spain Influenza Treatment Market by Administration Route, 2019-2030, USD mn 89

Table 32. Spain Influenza Treatment Market by Distribution Channel, 2019-2030, USD mn 89

Table 33. Italy Influenza Treatment Market by Product Type, 2019-2030, USD mn 91

Table 34. Italy Influenza Treatment Market by Administration Route, 2019-2030, USD mn 91

Table 35. Italy Influenza Treatment Market by Distribution Channel, 2019-2030, USD mn 91

Table 36. Russia Influenza Treatment Market by Product Type, 2019-2030, USD mn 93

Table 37. Russia Influenza Treatment Market by Administration Route, 2019-2030, USD mn 93

Table 38. Russia Influenza Treatment Market by Distribution Channel, 2019-2030, USD mn 93

Table 39. Influenza Treatment Market in Rest of Europe by Country, 2019-2030, USD mn 95

Table 40. APAC Influenza Treatment Market by Country, 2019-2030, USD mn 98

Table 41. Japan Influenza Treatment Market by Product Type, 2019-2030, USD mn 102

Table 42. Japan Influenza Treatment Market by Administration Route, 2019-2030, USD mn 102

Table 43. Japan Influenza Treatment Market by Distribution Channel, 2019-2030, USD mn 102

Table 44. China Influenza Treatment Market by Product Type, 2019-2030, USD mn 104

Table 45. China Influenza Treatment Market by Administration Route, 2019-2030, USD mn 104

Table 46. China Influenza Treatment Market by Distribution Channel, 2019-2030, USD mn 104

Table 47. Australia Influenza Treatment Market by Product Type, 2019-2030, USD mn 106

Table 48. Australia Influenza Treatment Market by Administration Route, 2019-2030, USD mn 106

Table 49. Australia Influenza Treatment Market by Distribution Channel, 2019-2030, USD mn 106

Table 50. India Influenza Treatment Market by Product Type, 2019-2030, USD mn 108

Table 51. India Influenza Treatment Market by Administration Route, 2019-2030, USD mn 108

Table 52. India Influenza Treatment Market by Distribution Channel, 2019-2030, USD mn 108

Table 53. South Korea Influenza Treatment Market by Product Type, 2019-2030, USD mn 110

Table 54. South Korea Influenza Treatment Market by Administration Route, 2019-2030, USD mn 110

Table 55. South Korea Influenza Treatment Market by Distribution Channel, 2019-2030, USD mn 110

Table 56. Influenza Treatment Market in Rest of APAC by Country, 2019-2030, USD mn 112

Table 57. South America Influenza Treatment Market by Country, 2019-2030, USD mn 115

Table 58. Argentina Influenza Treatment Market by Product Type, 2019-2030, USD mn 117

Table 59. Argentina Influenza Treatment Market by Administration Route, 2019-2030, USD mn 117

Table 60. Argentina Influenza Treatment Market by Distribution Channel, 2019-2030, USD mn 117

Table 61. Brazil Influenza Treatment Market by Product Type, 2019-2030, USD mn 119

Table 62. Brazil Influenza Treatment Market by Administration Route, 2019-2030, USD mn 119

Table 63. Brazil Influenza Treatment Market by Distribution Channel, 2019-2030, USD mn 119

Table 64. Chile Influenza Treatment Market by Product Type, 2019-2030, USD mn 121

Table 65. Chile Influenza Treatment Market by Administration Route, 2019-2030, USD mn 121

Table 66. Chile Influenza Treatment Market by Distribution Channel, 2019-2030, USD mn 121

Table 67. MEA Influenza Treatment Market by Country, 2019-2030, USD mn 125

Table 68. UAE Influenza Treatment Market by Product Type, 2019-2030, USD mn 127

Table 69. UAE Influenza Treatment Market by Administration Route, 2019-2030, USD mn 127

Table 70. UAE Influenza Treatment Market by Distribution Channel, 2019-2030, USD mn 127

Table 71. Saudi Arabia Influenza Treatment Market by Product Type, 2019-2030, USD mn 129

Table 72. Saudi Arabia Influenza Treatment Market by Administration Route, 2019-2030, USD mn 129

Table 73. Saudi Arabia Influenza Treatment Market by Distribution Channel, 2019-2030, USD mn 129

Table 74. South Africa Influenza Treatment Market by Product Type, 2019-2030, USD mn 131

Table 75. South Africa Influenza Treatment Market by Administration Route, 2019-2030, USD mn 131

Table 76. South Africa Influenza Treatment Market by Distribution Channel, 2019-2030, USD mn 131

Table 77. AstraZeneca Plc: Company Snapshot 137

Table 78. AstraZeneca Plc: Business Segmentation 137

Table 79. AstraZeneca Plc: Product Portfolio 138

Table 80. AstraZeneca Plc: Revenue, 2016-2018, USD mn 138

Table 81. AstraZeneca Plc: Recent Developments 138

Table 82. Risk Evaluation for Investing in Global Market, 2019-2030 151

Table 83. Critical Success Factors and Key Takeaways 154

You can also purchase parts of this report. Do you want to check out a section wise price list?

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022

What Our Clients Say About Us